BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35897796)

  • 1. The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies.
    Xu J; Li L; Shi P; Cui H; Yang L
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells.
    Ma N; Zhao S; Yang W; Wang Y
    Arab J Gastroenterol; 2023 Aug; 24(3):168-174. PubMed ID: 36878814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer.
    Hu C; Zhang Q; Tang Q; Zhou H; Liu W; Huang J; Liu Y; Wang Q; Zhang J; Zhou M; Sheng F; Lai W; Tian J; Li G; Zhang R
    J Cell Mol Med; 2020 Jan; 24(1):618-631. PubMed ID: 31724308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
    Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
    J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of B-cell-specific Moloney murine leukemia virus integration site 1 mRNA and protein in gastric cancer.
    Liu PW; Lin Y; Chen XY
    J Dig Dis; 2014 Apr; 15(4):166-73. PubMed ID: 24393364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN/Akt signaling in pancreatic cancer.
    Ni S; Wang H; Zhu X; Wan C; Xu J; Lu C; Xiao L; He J; Jiang C; Wang W; He Z
    Oncotarget; 2017 Jan; 8(5):8010-8021. PubMed ID: 28030829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMI-1 Promotes Self-Renewal of Radio- and Temozolomide (TMZ)-Resistant Breast Cancer Cells.
    Yan Y; Wang Y; Zhao P; Ma W; Hu Z; Zhang K
    Reprod Sci; 2017 Dec; 24(12):1620-1629. PubMed ID: 28270035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S; Tetzlaff MT; Cui R; Xu X
    Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells.
    Xu X; Liu Y; Su J; Li D; Hu J; Huang Q; Lu M; Liu X; Ren J; Chen W; Sun L
    Oncol Rep; 2016 Feb; 35(2):923-31. PubMed ID: 26573774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of BMI-1 protein in cancer.
    Zaczek A; Jóźwiak P; Krześlak A
    Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):811-824. PubMed ID: 28931748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    M JR; S V
    Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.
    Wu C; Zheng X; Li X; Fesler A; Hu W; Chen L; Xu B; Wang Q; Tong A; Burke S; Ju J; Jiang J
    Oncotarget; 2016 Mar; 7(12):14522-36. PubMed ID: 26894855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bmi-1 in pediatric brain tumors as a new independent prognostic marker of patient survival.
    Farivar S; Zati Keikha R; Shiari R; Jadali F
    Biomed Res Int; 2013; 2013():192548. PubMed ID: 23984324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma.
    Kalish JM; Tang XH; Scognamiglio T; Zhang T; Gudas LJ
    Cancer Biol Ther; 2020 May; 21(5):400-411. PubMed ID: 32037955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.
    Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K
    Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
    Liu L; Qiu M; Tan G; Liang Z; Qin Y; Chen L; Chen H; Liu J
    J Transl Med; 2014 Nov; 12():305. PubMed ID: 25367080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
    Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
    Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
    Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
    Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.